Double blind, randomised, placebo controlled study to evaluate the safety, tolerability and pharmacokinetics of single doses of GSK1014802 and the effect of single doses of GSK1014802 or lamotrigine on resting motor threshold in healthy volunteers.

Trial Profile

Double blind, randomised, placebo controlled study to evaluate the safety, tolerability and pharmacokinetics of single doses of GSK1014802 and the effect of single doses of GSK1014802 or lamotrigine on resting motor threshold in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Mar 2012

At a glance

  • Drugs Raxatrigine (Primary) ; Lamotrigine
  • Indications Absence epilepsy; Bipolar disorders; Depressive disorders; Lennox-Gastaut syndrome; Neuropathic pain; Partial epilepsies; Tonic-clonic epilepsy
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 18 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top